Early-onset Alzheimer's Disease: Nonamnestic Subtypes and Type 2 AD

Archives of Medical Research

Volumn 43, Issue 8, 2012, Pages 677-685

  Mendez, Mario F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amnestic; Apolipoprotein; Dementia; Presenilin

Indexed keywords

APOLIPOPROTEIN E4; PRESENILIN 1; PRESENILIN 2;

ADULT; ALZHEIMER DISEASE; AMNESIA; BRAIN REGION; COGNITIVE DEFECT; EARLY ONSET ALZHEIMER DISEASE; FEMALE; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; PATHOPHYSIOLOGY; REVIEW;

AGE OF ONSET; ALZHEIMER DISEASE; AMNESIA; APOLIPOPROTEINS E; BRAIN; COGNITION; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMORY; NEUROIMAGING; VISUAL PERCEPTION;

EID: 84871645829     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.11.009     Document Type: Review

References (102)

1. Alzheimer A., Stelzmann R.A., Schnitzlein H.N., et al. An English translation of Alzheimer's 1907 paper, Uber eine eigenartige Erkankung der Hirnrinde. Clin Anat 1995, 8:429-431.
2. Blessed G., Tomlinson B.E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968, 114:797-811.
3. Katzman R. Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol 1976, 33:217-218.
4. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
5. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N Engl J Med 2010, 362:329-344.
6. Bickel H., Burger K., Hampel H., et al. Nervenarzt 2006, 77:1079-1085.
7. Renvoize E., Hanson M., Dale M. Prevalence and causes of young onset dementia in an English health district. Int J Geriatr Psychiatry 2011, 26:106-107.
8. Alzheimer's A. Early-Onset Dementia: A National Challenge, A Future Crisis 2006, Alzheimer's Association, Washington, DC.
9. McMurtray A., Clark D.G., Christine D., et al. Early-onset dementia: frequency and causes compared to late-onset dementia. Dement Geriatr Cogn Disord 2006, 21:59-64.
10. McMurtray A.M., Ringman J., Chao S.Z., et al. Family history of dementia in early-onset versus very late-onset Alzheimer's disease. Int J Geriatr Psychiatry 2006, 21:597-598.
11. van der Flier W.M., Pijnenburg Y.A., Fox N.C., et al. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE varepsilon4 allele. Lancet Neurol 2011, 10:280-288.
12. van der Flier W.M., Schoonenboom S.N., Pijnenburg Y.A., et al. The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology 2006, 67:526-527.
13. Lind J., Larsson A., Persson J., et al. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett 2006, 396:23-27.
14. Reiman E.M., Chen K., Alexander G.E., et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004, 101:284-289.
15. Davidson Y., Gibbons L., Pritchard A., et al. Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease. Dement Geriatr Cogn Disord 2007, 23:60-66.
16. Schott J.M., Ridha B.H., Crutch S.J., et al. Apolipoprotein e genotype modifies the phenotype of Alzheimer disease. Arch Neurol 2006, 63:155-156.
17. Rogalski E.J., Rademaker A., Harrison T.M., et al. ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias. Alzheimer Dis Assoc Disord 2011, 25:159-163.
18. Balasa M., Gelpi E., Antonell A., et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology 2011, 76:1720-1725.
19. Larner A.J., Doran M. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol 2006, 253:139-158.
20. Joshi A., Ringman J.M., Lee A.S., et al. Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease. J Neurol 2012, 259:2182-2188.
21. Goldman J.S., Hahn S.E., Catania J.W., et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med 2011, 13:597-605.
22. Llado A., Fortea J., Ojea T., et al. A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression. Eur J Neurol 2010, 17:994-996.
23. Bertram L. Alzheimer's genetics in the GWAS era: a continuing story of replications and refutations. Curr Neurol Neurosci Rep 2011, 11:246-253.
24. La Rue A., O'Hara R., Matsuyama S.S., et al. Cognitive changes in young-old adults: effect of family history of dementia. J Clin Exp Neuropsychol 1995, 17:65-70.
25. Wingo T.S., Lah J.J., Levey A.I., et al. Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol 2012, 69:59-64.
26. Brickell K.L., Steinbart E.J., Rumbaugh M., et al. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease. Arch Neurol 2006, 63:1307-1311.
27. Sorrell J.M., Durham S. Meeting the mental health needs of the aging veteran population. J Psychosoc Nurs Ment Health Serv 2011, 49:22-25.
28. Yaffe K., Vittinghoff E., Lindquist K., et al. Posttraumatic stress disorder and risk of dementia among US veterans. Arch Gen Psychiatry 2010, 67:608-613.
29. Johnson V.E., Stewart W., Smith D.H. Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer's disease?. Nat Rev Neurosci 2010, 11:361-370.
30. Baugh C.M., Stamm J.M., Riley D.O., et al. Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma. Brain Imaging Behav 2012, 6:244-254.
31. Mendez M.F., Lee A.S., Joshi A., et al. Nonamnestic presentations of early-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen 2012, 27:413-420.
32. Alladi S., Xuereb J., Bak T., et al. Focal cortical presentations of Alzheimer's disease. Brain 2007, 130:2636-2645.
33. Koedam E.L., Lauffer V., van der Vlies A.E., et al. Early-versus late-onset Alzheimer's disease: more than age alone. J Alzheimers Dis 2010, 19:1401-1408.
34. Stopford C.L., Snowden J.S., Thompson J.C., et al. Variability in cognitive presentation of Alzheimer's disease. Cortex 2008, 44:185-195.
35. McKhann G.M., Knopman D.S., Chertkow H., et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:263-269.
36. Koedam E.L., Pijnenburg Y.A., Deeg D.J., et al. Early-onset dementia is associated with higher mortality. Dement Geriatr Cogn Disord 2008, 26:147-152.
37. Rogaeva E. The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease. Neuromolecular Med 2002, 2:1-10.
38. Smits L.L., Pijnenburg Y.A., Koedam E.L., et al. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 2012, 30:101-108.
39. Migliaccio R., Agosta F., Toba M.N., et al. Brain networks in posterior cortical atrophy: a single case tractography study and literature review. Cortex 2012, 48:1298-1309.
40. Gorno-Tempini M.L., Hillis A.E., Weintraub S., et al. Classification of primary progressive aphasia and its variants. Neurology 2011, 76:1006-1014.
41. Tsai P.H., Teng E., Liu C., et al. Posterior cortical atrophy: evidence for discrete syndromes of early-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen 2011, 26:413-418.
42. Mendez M.F., Ghajarania M., Perryman K.M. Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr Cogn Disord 2002, 14:33-40.
43. Tang-Wai D., Mapstone M. What are we seeing? Is posterior cortical atrophy just Alzheimer disease?. Neurology 2006, 66:300-301.
44. Mathew R., Bak T.H., Hodges J.R. Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry 2012, 83:405-410.
45. Sa F., Pinto P., Cunha C., et al. Differences between early and late-onset Alzheimer's disease in neuropsychological tests. Front Neurol 2012, 3:81.
46. Koss E., Edland S., Fillenbaum G., et al. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: a CERAD analysis, Part XII. Neurology 1996, 46:136-141.
47. Mendez M.F. The accurate diagnosis of early-onset dementia. Int J Psychiatry Med 2006, 36:401-412.
48. Frisoni G.B., Pievani M., Testa C., et al. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 2007, 130:720-730.
49. Licht E.A., McMurtray A.M., Saul R.E., et al. Cognitive differences between early- and late-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen 2007, 22:218-222.
50. Stopford C.L., Thompson J.C., Neary D., et al. Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia. Cortex 2012, 48:429-446.
51. Lee G.J., Lu P.H., Medina L.D., et al. Regional brain volume differences in symptomatic and pre-symptomatic carriers of familial Alzheimer's disease mutations. J Neurol Neurosurg Psychiatry 2012, [Epub ahead of print].
52. Kemppainen N.M., Aalto S., Wilson I.A., et al. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology 2006, 67:1575-1580.
53. Thal D.R., Rub U., Orantes M., et al. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.
54. Ishii K., Kawachi T., Sasaki H., et al. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am J Neuroradiol 2005, 26:333-340.
55. Kemp P.M., Holmes C., Hoffmann S.M., et al. Alzheimer's disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. J Neurol Neurosurg Psychiatry 2003, 74:715-719.
56. Scheltens P., Leys D., Barkhof F., et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992, 55:967-972.
57. Rabinovici G.D., Furst A.J., Alkalay A., et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 2010, 133:512-528.
58. Shiino A., Watanabe T., Maeda K., et al. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage 2006, 33:17-26.
59. Whitwell J.L., Jack C.R., Przybelski S.A., et al. Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging 2011, 32:1531-1541.
60. Ridgway G.R., Lehmann M., Barnes J., et al. Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology 2012, 79:80-84.
61. Migliaccio R., Agosta F., Rascovsky K., et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology 2009, 73:1571-1578.
62. Migliaccio R., Agosta F., Scola E., et al. Ventral and dorsal visual streams in posterior cortical atrophy: a DT MRI study. Neurobiol Aging 2012, 33:2572-2584.
63. Karas G., Scheltens P., Rombouts S., et al. Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology 2007, 49:967-976.
64. Rohrer J.D., Rossor M.N., Warren J.D. Alzheimer's pathology in primary progressive aphasia. Neurobiol Aging 2012, 33:744-752.
65. de Waal H., Stam C.J., Blankenstein M.A., et al. EEG abnormalities in early and late onset Alzheimer's disease: understanding heterogeneity. J Neurol Neurosurg Psychiatry 2011, 82:67-71.
66. Jagust W.J., Reed B.R., Seab J.P., et al. Alzheimer's disease. Age at onset and single-photon emission computed tomographic patterns of regional cerebral blood flow. Arch Neurol 1990, 47:628-633.
67. Kim E.J., Cho S.S., Jeong Y., et al. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain 2005, 128:1790-1801.
68. Sakamoto S., Ishii K., Sasaki M., et al. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J Neurol Sci 2002, 200:27-32.
69. Yasuno F., Imamura T., Hirono N., et al. Age at onset and regional cerebral glucose metabolism in Alzheimer's disease. Dement Geriatr Cogn Disord 1998, 9:63-67.
70. Mielke R., Herholz K., Grond M., et al. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging 1992, 13:93-98.
71. McMurtray A.M., Licht E., Yeo T., et al. Positron emission tomography facilitates diagnosis of early-onset Alzheimer's disease. Eur Neurol 2008, 59:31-37.
72. Lantos P.L., Luthert P.J., Hanger D., et al. Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett 1992, 137:221-224.
73. Mann U.M., Mohr E., Gearing M., et al. Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. J Neurol Neurosurg Psychiatry 1992, 55:956-959.
74. Kim S.H., Seo S.W., Yoon D.S., et al. Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: a five year longitudinal study. Dement Geriatr Cogn Disord 2010, 29:213-223.
75. Kaiser N.C., Melrose R.J., Collin Liu C., et al. Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease. Am J Alzheimer's Disease Other Dementias 2012, 27:520-529.
76. Ossenkoppele R., Zwan M.D., Tolboom N., et al. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Brain 2012, 135:2115-2125.
77. Barrio J.R., Satyamurthy N., Huang S.C., et al. Dissecting molecular mechanisms in the living brain of dementia patients. Acc Chem Res 2009, 42:842-850.
78. Jack C.R., Lowe V.J., Weigand S.D., et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132:1355-1365.
79. Choo I.H., Lee D.Y., Kim J.W., et al. Relationship of amyloid-beta burden with age-at-onset in Alzheimer disease. Am J Geriatr Psychiatry 2011, 19:627-634.
80. Rabinovici G.D., Jagust W.J., Furst A.J., et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008, 64:388-401.
81. Leyton C.E., Villemagne V.L., Savage S., et al. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using beta-amyloid imaging. Brain 2011, 134:3030-3043.
82. de Souza L.C., Corlier F., Habert M.O., et al. Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease. Brain 2011, 134:2036-2043.
83. Rosenbloom M.H., Alkalay A., Agarwal N., et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology 2011, 76:1789-1796.
84. Murray M.E., Graff-Radford N.R., Ross O.A., et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 2011, 10:785-796.
85. Marshall G.A., Fairbanks L.A., Tekin S., et al. Early-onset Alzheimer's disease is associated with greater pathologic burden. J Geriatr Psychiatry Neurol 2007, 20:29-33.
86. Gefen T., Gasho K., Rademaker A., et al. Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain 2012, 135:1554-1565.
87. Davidson Y.S., Raby S., Foulds P.G., et al. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 2011, 122:703-713.
88. Malkani R.G., Dickson D.W., Simuni T. Hippocampal-sparing Alzheimer's disease presenting as corticobasal syndrome. Parkinsonism Relat Disord 2012, 18:683-685.
89. Whitwell J.L., Shiung M.M., Przybelski S.A., et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008, 70:512-520.
90. Davatzikos C., Bhatt P., Shaw L.M., et al. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 2011, 32:2322. e19-27.
91. Bouwman F.H., Schoonenboom N.S., Verwey N.A., et al. CSF biomarker levels in early and late onset Alzheimer's disease. Neurobiol Aging 2009, 30:1895-1901.
92. Koric L., Felician O., Guedj E., et al. Could clinical profile influence CSF biomarkers in early-onset Alzheimer disease?. Alzheimer Dis Assoc Disord 2010, 24:278-283.
93. Bateman R.J., Xiong C., Benzinger T.L., et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012, 367:795-804.
94. Buchhave P., Minthon L., Zetterberg H., et al. Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 2012, 69:98-106.
95. Jack C.R., Knopman D.S., Jagust W.J., et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010, 9:119-128.
96. Sperling R.A., Aisen P.S., Beckett L.A., et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:280-292.
97. Kas A., de Souza L.C., Samri D., et al. Neural correlates of cognitive impairment in posterior cortical atrophy. Brain 2011, 134:1464-1478.
98. Vincent J.L., Kahn I., Snyder A.Z., et al. Evidence for a frontoparietal control system revealed by intrinsic functional connectivity. J Neurophysiol 2008, 100:3328-3342.
99. Jacobs H.I., Van Boxtel M.P., Heinecke A., et al. Functional integration of parietal lobe activity in early Alzheimer disease. Neurology 2012, 78:352-360.
100. Bao F., Wicklund L., Lacor P.N., et al. Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiol Aging 2012, 33:e1-e13.
101. Dorothee G., Bottlaender M., Moukari E., et al. Distinct patterns of antiamyloid-beta antibodies in typical and atypical Alzheimer disease: distinct patterns of anti-abeta antibodies and AD. Arch Neurol 2012, 69:1181-1185.
102. Hunt D.C. Young-onset dementia: a review of the literature and what it means for clinicians. J Psychosoc Nurs Ment Health Serv 2011, 49:28-33.